Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

The IBHRS is now operational.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

New genes and pathways are important for testosterone production and male sexual development.

Baricitinib is effective for severe alopecia areata but has some side effects.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Psoriasis or contact dermatitis can override alopecia areata, allowing hair growth.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

A 5-year-old Akita with a rare skin condition improved significantly after treatment.

Buschke-Ollendorff syndrome is a rare genetic disorder causing skin and bone changes, with some cases also showing ADHD or developmental delays.

New SRD5A2 variants may disrupt protein function, aiding diagnosis and treatment of related disorders.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

CDPDFM can improve acne symptoms in rabbit ears.

A Japanese patient with a rare genetic disorder had a less severe case than others, suggesting other factors may affect symptoms.

Certain drugs change freshwater snail shells to a "banana" shape.

Ganoderma lucidum extract and its component, ganoderic acid A, may effectively prevent hair loss.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Bicalutamide shows promise for treating female hair loss.

Kadali is a versatile medicinal plant used to treat various health issues.

Adiantum capillus-veneris may help with respiratory issues, but more research is needed.

ChatGPT is preferred for creating dermatology patient handouts, but all models can be useful with oversight.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

SAD patients show different brain activity patterns, which might help identify the disorder.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.